All In MedTech

Device Trial Radar · NCT03966768

DuraMesh Laparotomy Study

DuraMesh Laparotomy Closure Following Trauma and Emergency Surgery

Last checked: Nov 20, 2026Latest source record: Sep 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Oct 15, 2023

Primary completion

Dec 31, 2024

Study completion Dec 31, 2025

Sponsor

Lead sponsor
Mesh Suture Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Uniformed Services University of the Health Sciences; Walter Reed National Military Medical Center; University of Maryland
First posted
May 29, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. One hundred (100) patients will be randomized (2:1) to Duramesh laparotomy closure versus conventional suture closure. After the patient has been confirmed to be a candidate for the trial, randomization will be performed in the operating room upon completion of the index abdominal procedure. Duramesh will be provided for patients assigned to the Duramesh treatment arm. Patients will be followed for 1 year following laparotomy closure at follow-up intervals of 1 month, 3 months, 6 months, and 12 months.

Conditions

  • Laparotomy
  • Suture; Complications, Mechanical
  • Hernia Incisional

Interventions

  • Duramesh suturable mesh for laparotomy closureDevice

    Patients undergoing laparotomy will be closed with Duramesh suturable mesh

  • Conventional suture for laparotomy closureDevice

    Patients undergoing laparotomy will be closed with conventional polydiaxonone suture

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surgical site infectionTime frame: 1 month
  2. Surgical site infectionTime frame: 3 months
  3. Surgical site infectionTime frame: 6 months

1 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.